What is the difference between Cartalax and SNAP-8?

Cartalax: Tetrapeptide bioregulator from cartilage tissue; stimulates chondrocyte proliferation and extracellular matrix synthesis; normalizes gene expression in cartilage cells SNAP-8: Octapeptide extension of Argireline; competes with SNAP-25 for SNARE complex binding; reduces muscle contraction at neuromuscular junction

Is Cartalax FDA approved?

Cartalax is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is SNAP-8 FDA approved?

SNAP-8 is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Cartalax administered in research settings?

In research settings, Cartalax is typically administered via the subcutaneous or oral routes. PeptideBase does not provide dosing or administration instructions.

How is SNAP-8 administered in research settings?

In research settings, SNAP-8 is typically administered via the topical route. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Cartalax vs SNAP-8

Peptide Comparison

Cartalax vs SNAP-8

Name: Cartalax vs SNAP-8 — Per-mg Price Comparison
Creator: PeptideBase
License: https://peptidebase.io/terms

Both are Skin & Cosmetic peptides.

Cartalax

Ala-Glu-Asp-Arg

Skin & JointNot EvaluatedResearch Only

Half-life: Unknown

6 providers listed

Full Cartalax profile →

SNAP-8

Acetyl Octapeptide-3

Skin & JointNot EvaluatedResearch Only

Half-life: N/A (topical)

18 providers listed

Full SNAP-8 profile →

Bottom line

Cartalax has published research citations on file; SNAP-8 does not yet — the main evidence gap between them.

Quick Verdict

Cartalax

Evidence

Preclinical

SNAP-8

Evidence

Not rated

Which One Should You Choose?

Your goal	Better option
Has published research citations	Cartalax
Oral administration option	Cartalax
Lower typical price per mg	Cartalax
More provider options (6 vs 18)	SNAP-8

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Cartalax

SNAP-8

Mechanism Family

Skin & Cosmetic

Half-life

Unknown

N/A (topical)

FDA Status

not evaluated

Admin Routes

subcutaneous, oral

topical

Availability

Research Only

Providers

6 listed

18 listed

Avail. Notes

Russian joint/cartilage peptide bioregulator (Khavinson Institute). Not FDA-approved. Not on any FDA list. Research chemical in US.

Cosmetic peptide (acetyl octapeptide-3). SNAP-25 analog sold as topical anti-wrinkle cosmetic ingredient. Not regulated as a drug by FDA. No NDA or IND. Cosmetic use only.

Research Evidence

Cartalax

PreclinicalIn vitro · 1 key study · most recent 2023

SNAP-8

No citations on file

Research Citations

Cartalax

In vitro2023 · Advances in Gerontology

KE peptide regulates SIRT1, PARP1, PARP2 gene expression and protein synthesis in human mesenchymal stem cell…

SNAP-8

No citations on file.

About Cartalax

Tetrapeptide bioregulator from cartilage tissue; stimulates chondrocyte proliferation and extracellular matrix synthesis; normalizes gene expression in cartilage cells

Research Areas

cartilage regenerationjoint repairchondrocyte function support

About SNAP-8

Octapeptide extension of Argireline; competes with SNAP-25 for SNARE complex binding; reduces muscle contraction at neuromuscular junction

Research Areas

expression line reductionwrinkle depth decreaseanti-aging skin

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Cartalax

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

SNAP-8

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Price (per mg)

Cartalax

$2.75/mg

$2.06 – $3.00 range

12 vendors

View price index →Find providers →

SNAP-8

$3.50/mg

$3.15 – $3.90 range

10 vendors

View price index →Find providers →

Find Providers

Where to source these peptides

Providers offering

Cartalax

6 listed

Browse directory →

Providers offering

SNAP-8

18 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Skin & Cosmetic Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated July 20, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). Cartalax vs SNAP-8 — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/cartalax/snap-8

https://peptidebase.io/peptides/compare/cartalax/snap-8 Methodology License Download JSON Download CSV